Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response
- 7 August 2004
- journal article
- clinical trial
- Published by Elsevier BV in Vaccine
- Vol. 23 (5), 615-622
- https://doi.org/10.1016/j.vaccine.2004.07.014
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Maintenance of Serological Memory by Polyclonal Activation of Human Memory B CellsScience, 2002
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Adjuvant effects of CpG oligodeoxynucleotides on responses against T‐independent type 2 antigensImmunology, 2001
- CpG DNA rescues B cells from apoptosis by activating NFκB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathwayInternational Immunology, 1999
- In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigenJournal of Medical Virology, 1997
- Life and Death in Germinal Centers (Redux)Immunity, 1996
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers.The Journal of Experimental Medicine, 1992
- Maturation of the immune response in germinal centersCell, 1991
- The Role of Somatic Hypermutation in the Generation of Antibody DiversityScience, 1989